Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

INTRODUCTION: New target-specific oral anticoagulants may have benefits, such as shorter hospital length of stay, compared to warfarin in patients with nonvalvular atrial fibrillation (NVAF). This study aimed to assess, among patients with NVAF, the effect of rivaroxaban versus warfarin on health ca...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Adv Ther
Κύριοι συγγραφείς: Laliberté, François, Cloutier, Michel, Crivera, Concetta, Nelson, Winnie W., Olson, William H., Schein, Jeffrey, Vanderpoel, Julie, Germain, Guillaume, Lefebvre, Patrick
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Springer Healthcare 2015
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376962/
https://ncbi.nlm.nih.gov/pubmed/25784509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0189-1
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια